RPL7P44

Across TCGA pan-cancer cohorts, RPL7P44 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RPL7P44’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPL7P44 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL7P44 is over-expressed in tumor, although a few such as PAAD and UCEC show the opposite, repressed pattern.

KIRC, LIHC, and PAAD are the cancer types where RPL7P44 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL7P44 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.089	.002	6	view →
LIHC	All	All	+0.078	.001	5	view →
PAAD	Female	All	−0.555	.040	2	view →
READ	All	III,IV	+0.520	.029	2	view →
UCEC	All	All	−0.236	.032	2	view →
THCA	All	All	−0.096	.035	2	view →
KICH	Male	All	+0.154	.018	1	view →
LUSC	All	All	+0.084	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

RPL7P44–KIRC

Open the KIRC breakdown →